Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated October 18, 2023, serves as a transaction notification for the month of October 2023. The document details specific share transactions executed by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. These transactions were conducted on October 16, 2023, on the London Stock Exchange (XLON) and the New York Stock Exchange (XNYS).
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, or debt metrics for GSK plc. It exclusively reports on individual share transactions. Key transaction data points include:
- Transaction Type: Increase in notional interest or acquisition of shares via dividend re-investment.
- Instrument: Ordinary Shares (ISIN: GB00BN7SWP63) and American Depositary Shares (ADSs) (ISIN: US37733W2044).
- Transaction Price: Ordinary Shares at £15.1980; ADSs at $37.0100.
- Volume: Individual transaction volumes ranged from 23 ADSs to 5,020.201 Ordinary Shares.
Material Changes
The filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. The changes disclosed are limited to the increase in shareholdings of specific executives resulting from the re-investment of dividends paid on October 12, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. The transactions were executed under the Company's Deferred Annual Bonus Plan and Performance Share Plan. One transaction by the CEO, Emma Walmsley, is noted as being subject to a 2-year holding period.
Investor Verification Checklist
- Verify the total number of shares acquired by each PDMR listed in the filing against their total beneficial ownership.
- Confirm the dividend payment date of October 12, 2023, and the corresponding ex-dividend date.
- Review the specific terms of the Deferred Annual Bonus Plan and Performance Share Plan regarding holding periods and vesting.
- Check the market price of GSK Ordinary Shares and ADSs on October 16, 2023, to validate the transaction prices of £15.1980 and $37.0100.